BN Business News
Add your company to Business Communicator →

Business · 19/12/2017Updated: 10/17/2026 · 1 min read

FDA Announces Public Workshop on Generic Orally Inhaled and Nasal Drug Products

Summary

The FDA is hosting a public workshop to discuss new insights on product development and bioequivalence assessments for generic OINDPs, seeking input on analytical methods and procedures for ANDA submissions.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →